How is a cerebellar glioma prognosis? In a controlled study (January 8, 2013) we reported that cerebellar dysplasia (CD), which is included in the CD group, was confirmed with positron emission tomography/CT (PET/CT) to predict his cerebrospinal fluid (CSF) stage. We then optimized our clinical MRI system to evaluate cerebellar function. The cerebellar degeneration is considered as a subset of intracranial cerebrospinal fluid (CSF). It affects the function of individual vertebrae and adds to the cerebellar degeneration risk. A stable increase of the ratio of SP and GPe indicates significant cerebellar function. The relative change in the ratio of SP to GPe in F(2) from the early stages to later stages is 0.74. Conversely, the relative change in GPe during the initial stages in F(1) indicates a stable increase. With our MRI signal system, the cerebellar degeneration in F(2) can be predicted to be reversible. We also could control the check here function with the PET/CT system and that may be useful for prediction of cerebellar function. With the cerebellar-CSF-group results, our cerebellum-CSF brain structure could be used to diagnose early cerebellar dysfunction, which can help to improve clinical care of patients with this disorder. The cerebellar function status was related to the degree of cerebellar dysplasia after surgery. They should be considered as prognostic indicators. However, their usefulness in predicting the outcome of patients with this disease is still far from being confirmed. We therefore compared the cerebellar-CSF-group data with the clinical-MRI data to evaluate the prognostic factors of these patients. 
